Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vonoprazan + minocycline dual therapy versus bismuth quadruple therapy for Helicobacter pylori eradication
ChiCTR2500098536Phase 4Recruiting
- Sponsor
- Army Medical Center of PLA
- Start
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of vonoprazan and minocycline in Helicobacter pylori infection (2 arms), sponsored by Army Medical Center of PLA. Primary endpoint: Eradication rate. Started Mar 2025; status: recruiting.
02
Drugs
vonoprazanminocycline
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on ChiCTR2500098536.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500098536.